TY - JOUR
T1 - A clinical approach to circadian rhythm sleep disorders
AU - Barion, Ana
AU - Zee, Phyllis C.
N1 - Funding Information:
Ana Barion has nothing to disclose. Phyllis C. Zee has served as a consultant for Boeringher Ingelheim, Glaxo Smith Kline, Neurocrine Biosciences, Pfizer, Sanofi-Aventis, Sepracor and Takeda Pharmaceutical. Dr. Zee has also served as an investigator on research grants funded by Boeringher Ingelheim, Glaxo Smith Kline, Neurocrine Biosciences, Sanofi-Aventis and Takeda Pharmaceuticals.
PY - 2007/9
Y1 - 2007/9
N2 - Circadian rhythm sleep disorders are characterized by complaints of insomnia and excessive sleepiness that are primarily due to alterations in the internal circadian timing system or a misalignment between the timing of sleep and the 24-h social and physical environment. In addition to physiological and environmental factors, maladaptive behaviors often play an important role in the development of many of the circadian rhythm sleep disorders. This review will focus on the clinical approach to the diagnosis and management of the various circadian rhythm sleep disorders, including delayed sleep phase disorder, advanced sleep phase disorder, non-entrained type, irregular sleep-wake rhythm, shift work sleep disorder and jet lag disorder. Diagnostic tools such as sleep diaries and wrist activity monitoring are often useful in confirming the diagnosis. Because behavioral and environmental factors often are involved in the development of these conditions, a multimodal approach is usually necessary. Interventions include sleep hygiene education, timed exposure to bright light as well as avoidance of bright light at the wrong time of the day and pharmacologic approaches, such as melatonin. However, it should be noted that the use of melatonin is not an FDA-approved indication for the treatment of circadian rhythm sleep disorders.
AB - Circadian rhythm sleep disorders are characterized by complaints of insomnia and excessive sleepiness that are primarily due to alterations in the internal circadian timing system or a misalignment between the timing of sleep and the 24-h social and physical environment. In addition to physiological and environmental factors, maladaptive behaviors often play an important role in the development of many of the circadian rhythm sleep disorders. This review will focus on the clinical approach to the diagnosis and management of the various circadian rhythm sleep disorders, including delayed sleep phase disorder, advanced sleep phase disorder, non-entrained type, irregular sleep-wake rhythm, shift work sleep disorder and jet lag disorder. Diagnostic tools such as sleep diaries and wrist activity monitoring are often useful in confirming the diagnosis. Because behavioral and environmental factors often are involved in the development of these conditions, a multimodal approach is usually necessary. Interventions include sleep hygiene education, timed exposure to bright light as well as avoidance of bright light at the wrong time of the day and pharmacologic approaches, such as melatonin. However, it should be noted that the use of melatonin is not an FDA-approved indication for the treatment of circadian rhythm sleep disorders.
KW - Advanced sleep phase disorder
KW - Circadian rhythm sleep disorders
KW - Delayed sleep phase disorder
KW - Irregular sleep-wake rhythm
KW - Jet lag syndrome
KW - Non 24-h sleep-wake syndrome
KW - Shift work disorder
UR - http://www.scopus.com/inward/record.url?scp=34547502731&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=34547502731&partnerID=8YFLogxK
U2 - 10.1016/j.sleep.2006.11.017
DO - 10.1016/j.sleep.2006.11.017
M3 - Article
C2 - 17395535
AN - SCOPUS:34547502731
SN - 1389-9457
VL - 8
SP - 566
EP - 577
JO - Sleep Medicine
JF - Sleep Medicine
IS - 6
ER -